Order Article Reprints

Ghersin I, Fischman M, Calini G, Koifman E, Celentano V, Segal JP, Argyriou O, McLaughlin SD, Johnson H, Rottoli M, et al. Long-Term Outcomes of First-Line Anti-TNF Therapy for Chronic Inflammatory Pouch Conditions: A Multi-Centre Multi-National Study. Biomedicines. 2025; 13(8):1870. https://doi.org/10.3390/biomedicines13081870

Ghersin, Itai, Maya Fischman, Giacomo Calini, Eduard Koifman, Valerio Celentano, Jonathan P. Segal, Orestis Argyriou, Simon D. McLaughlin, Heather Johnson, Matteo Rottoli, and et al. 2025. "Long-Term Outcomes of First-Line Anti-TNF Therapy for Chronic Inflammatory Pouch Conditions: A Multi-Centre Multi-National Study" Biomedicines 13, no. 8: 1870. https://doi.org/10.3390/biomedicines13081870

Ghersin, I., Fischman, M., Calini, G., Koifman, E., Celentano, V., Segal, J. P., Argyriou, O., McLaughlin, S. D., Johnson, H., Rottoli, M., Sahnan, K., Warusavitarne, J., & Hart, A. L. (2025). Long-Term Outcomes of First-Line Anti-TNF Therapy for Chronic Inflammatory Pouch Conditions: A Multi-Centre Multi-National Study. Biomedicines, 13(8), 1870. https://doi.org/10.3390/biomedicines13081870